Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test
Authors Lu B, Kudlowitz D, Gardner L
Received 9 June 2015
Accepted for publication 26 August 2015
Published 19 November 2015 Volume 2015:6 Pages 277—283
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Hitesh Soni
Peer reviewer comments 3
Editor who approved publication: Dr Martin Bluth
Benjamin Y Lu,1 David Kudlowitz,1, Lawrence B Gardner1–3
1Department of Medicine, 2Department of Biochemistry and Molecular Pharmacology, 3The Perlmutter Cancer Center, NYU Langone Medical Center, NYU School of Medicine, New York, NY, USA
Purpose: Diagnosing heparin-induced thrombocytopenia, a potentially catastrophic immune-mediated disorder, continues to pose significant challenges for clinicians, as both clinical and laboratory tools lack specificity. There is mounting evidence supporting a positive correlation between definitive heparin-induced thrombocytopenia and optical density (OD) positivity from the widely available anti-platelet factor 4 enzyme-linked immunosorbent assays (PF4 ELISAs). However, the clinical features distinguishing these patients remain poorly understood.
Patients and methods: To better characterize this group, we conducted a case-controlled, retrospective chart review of patients from two large, urban academic institutions who underwent a PF4 ELISA at a central laboratory. Associations between OD and 18 clinical characteristics were calculated using the Fisher's exact test for categorical variables and Wilcoxon rank-sum test for continuous variables.
Results: In total, 184 negative patients (OD <0.7), and 121 positive patients (OD >0.7), including 74 low-positive patients (0.7, OD <1.4) and 47 high-positive patients (OD >1.4) were identified. Several clinical variables were significantly different in the negative group compared with the positive group, including hospital day (P<0.001), previous admission within the past 3 months (P<0.001), and the presence of a new thrombus (P=0.003). However, many of these variables were not different between the negative and low-positive group, and were only distinct between the negative and high-positive group. When the low-positive and high-positive groups were compared, only the 4T score was significantly different (P=0.003).
Conclusion: These data indicate that those with OD >1.4 form a distinct clinical group and support the clinical utility of the 4T score.
Keywords: heparin-induced thrombocytopenia, platelet factor 4 ELISA, thrombocytopenia, HIT, heparin
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]